25.99
+0.5(+1.96%)
Currency In USD
| Previous Close | 25.49 |
| Open | 25.49 |
| Day High | 26.24 |
| Day Low | 25.04 |
| 52-Week High | 39.92 |
| 52-Week Low | 18.35 |
| Volume | 147,341 |
| Average Volume | 63,954 |
| Market Cap | 311.76M |
| PE | 34.65 |
| EPS | 0.75 |
| Moving Average 50 Days | 31.79 |
| Moving Average 200 Days | 28.57 |
| Change | 0.5 |
If you invested $1000 in XOMA Royalty Corp. (XOMA) 10 years ago, it would be worth $941.67 as of December 25, 2025 at a share price of $25.99. Whereas If you bought $1000 worth of XOMA Royalty Corp. (XOMA) shares 5 years ago, it would be worth $581.17 as of December 25, 2025 at a share price of $25.99.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc
GlobeNewswire Inc.
Dec 05, 2025 2:00 PM GMT
EMERYVILLE, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA), the biotech royalty aggregator, today announced it has successfully completed its previously announced acquisition of the entire issued
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.
GlobeNewswire Inc.
Nov 21, 2025 12:45 PM GMT
EMERYVILLE, Calif., Nov. 21, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA) today announced it has successfully completed its previously announced acquisition of all the outstanding common shares of LAVA Therapeut
XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement
GlobeNewswire Inc.
Oct 17, 2025 3:45 PM GMT
- Amendment includes finalized cash amount and updated CVR terms for tender offer - LAVA announces new date for extraordinary general meeting of shareholders EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Penn., Oct. 17, 2025 (G